New Medications

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
Woman taking a pill
FDA Alert
FDA Approves First Antipsychotic Medication Targeting Cholinergic Receptors for Patients With Schizophrenia
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024
FDA Alert
fda
FDA Alert
FDA Approves Irinotecan Liposome For First-Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
03/04/2024
Anthony Calabro, MA
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
03/04/2024
FDA Alert
FDA Alert
FDA Alert
FDA Approves Two Medications to Treat Pediatric Patients With Type 2 Diabetes
08/10/2023
Jessica Ganga
The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.
08/10/2023
FDA Alert
Child holding stomach
FDA Alert
First Treatment for Pediatric Functional Constipation Approved by FDA
06/15/2023
Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
FDA ALERTS
FDA ALERTS
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis
FDA Approves New Medication for Treatment of ALS
10/07/2022
The recent FDA approval of a new oral treatment for patients with amyotrophic lateral sclerosis (ALS) adds another option for individuals who are diagnosed with the non-curable disease.
10/07/2022
Medication
Medication
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
09/20/2022
The FDA approved an intravenous infusion medication to treat symptoms of this rare genetic disease that affects the liver, spleen, lung, and brain.
09/20/2022
Treatment
Treatment
FDA Approves First Treatment for Active Psoriatic Arthritis in Pediatric Patients
08/23/2022
The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.
08/23/2022